Cargando…

Bone Marrow Stromal Antigen 2 is a Potential Unfavorable Prognostic Factor for High-Grade Glioma

BACKGROUND: Bone marrow stromal antigen 2 (BST2) is considered as a transmembrane glycoprotein and plays essential roles in innate immunity. It has been recently reported that up-regulation of BST2 was associated with the development of breast carcinoma. However, the clinical significance of BST2 in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Haiping, Luo, Ke, Huang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468947/ https://www.ncbi.nlm.nih.gov/pubmed/32943880 http://dx.doi.org/10.2147/OTT.S258631

Ejemplares similares

Upregulated necroptosis-pathway-associated genes are unfavorable prognostic markers in low-grade glioma and glioblastoma multiforme
por: Dong, Yuanli, et al.
Publicado: (2019)

TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
por: Xie, Sidi, et al.
Publicado: (2021)

Expression of neuropilin-1 is linked to glioma associated microglia and macrophages and correlates with unfavorable prognosis in high grade gliomas
por: Caponegro, Michael D., et al.
Publicado: (2018)

Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas
por: van Thuijl, Hinke F, et al.
Publicado: (2014)

High expression of TXNDC11 indicated unfavorable prognosis of glioma
por: Peng, Peng, et al.
Publicado: (2021)

Identification of aurora kinase A as an unfavorable prognostic factor and potential treatment target for metastatic gastrointestinal stromal tumors
por: Yeh, Chun-Nan, et al.
Publicado: (2014)

Low expression of CDHR1 is an independent unfavorable prognostic factor in glioma
por: Wang, Haiwei, et al.
Publicado: (2021)

The Manufacture of GMP-Grade Bone Marrow Stromal Cells with Validated In Vivo Bone-Forming Potential in an Orthopedic Clinical Center in Brazil
por: Dias, Rhayra B., et al.
Publicado: (2019)

Stromal micropapillary component as a novel unfavorable prognostic factor of lung adenocarcinoma
por: Ohe, Miki, et al.
Publicado: (2012)

Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value
por: Doghri, Raoudha, et al.
Publicado: (2017)

Transcriptomic reappraisal identifies MGLL overexpression as an unfavorable prognosticator in primary gastrointestinal stromal tumors
por: Li, Chien-Feng, et al.
Publicado: (2016)

Hepatoma-derived growth factor functions as an unfavorable prognostic marker of human gliomas
por: Yang, Yang, et al.
Publicado: (2017)

S100A11 Promotes Glioma Cell Proliferation and Predicts Grade-Correlated Unfavorable Prognosis
por: Wang, Haopeng, et al.
Publicado: (2021)

Comparison of Tumor- and Bone Marrow-Derived Mesenchymal Stromal/Stem Cells from Patients with High-Grade Osteosarcoma
por: Le Nail, Louis-Romée, et al.
Publicado: (2018)

Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma
por: Decraene, Brecht, et al.
Publicado: (2022)

Bone marrow stroma cells promote induction of a chemoresistant and prognostic unfavorable S100A8/A9(high) AML cell subset
por: Böttcher, Martin, et al.
Publicado: (2022)

Molecular pathogenesis and prognostication of "low‐grade'' and "high‐grade" endometrial stromal sarcoma
por: Micci, Francesca, et al.
Publicado: (2020)

High expression of six-transmembrane epithelial antigen of prostate 3 promotes the migration and invasion and predicts unfavorable prognosis in glioma
por: Deng, Langmei, et al.
Publicado: (2023)

High Stromal SFRP2 Expression in Urothelial Carcinoma Confers an Unfavorable Prognosis
por: Lai, Hong-Yue, et al.
Publicado: (2022)

PD-L2 expression is correlated with the molecular and clinical features of glioma, and acts as an unfavorable prognostic factor
por: Wang, Zhi-liang, et al.
Publicado: (2018)

Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome-Based Verification Study
por: Chiang, Sum-Fu, et al.
Publicado: (2015)

Endothelial cells influence the osteogenic potential of bone marrow stromal cells
por: Xue, Ying, et al.
Publicado: (2009)

Metformin as Potential Therapy for High-Grade Glioma
por: Mazurek, Marek, et al.
Publicado: (2020)

Age is associated with unfavorable neuropathological and radiological features and poor outcome in patients with WHO grade 2 and 3 gliomas
por: Krigers, Aleksandrs, et al.
Publicado: (2021)

Connective tissue growth factor as an unfavorable prognostic marker promotes the proliferation, migration, and invasion of gliomas
por: Song, Zi-Bin, et al.
Publicado: (2020)

CKMT1B is a potential prognostic biomarker and associated with immune infiltration in Lower-grade glioma
por: Shi, Huadi, et al.
Publicado: (2021)

Multicellular “hotspots” harbor high-grade potential in lower-grade gliomas
por: Kirby, Alastair J, et al.
Publicado: (2021)

Publisher Correction: Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma
por: Decraene, Brecht, et al.
Publicado: (2022)

Integrin Alpha-2 as a Potential Prognostic and Predictive Biomarker for Patients With Lower-Grade Glioma
por: Lin, Li, et al.
Publicado: (2021)

Osteogenic potentials of osteophytes in the cervical spine compared with patient matched bone marrow stromal cells
por: Zhao, Pei, et al.
Publicado: (2013)

High expression of PYCARD is an independent predictor of unfavorable prognosis and chemotherapy resistance in glioma
por: Liang, Aijun, et al.
Publicado: (2021)

High expression of HOXA4 in patients with glioma indicates unfavorable clinical outcomes
por: Yu, Zhenghong, et al.
Publicado: (2022)

Down-regulation of SOCS6: an unfavorable prognostic factor for gastrointestinal stromal tumor proven by survival analysis
por: Ouyang, Jun, et al.
Publicado: (2021)

Standard toxicity study of clinical-grade allogeneic human bone marrow-derived clonal mesenchymal stromal cells
por: Tayebi, Behnoosh, et al.
Publicado: (2022)

Bone marrow stromal antigen 2 expressed in cancer cells promotes mammary tumor growth and metastasis
por: Mahauad-Fernandez, Wadie D, et al.
Publicado: (2014)

Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma
por: Mou, Yanhua, et al.
Publicado: (2022)

Dissecting the Role of Bone Marrow Stromal Cells on Bone Metastases
por: Buenrostro, Denise, et al.
Publicado: (2014)

Spatial organization of heterogeneous immunotherapy target antigen expression in high-grade glioma
por: Barish, Michael E., et al.
Publicado: (2022)

Adipose-derived stromal cells resemble bone marrow stromal cells in hepatocyte differentiation potential in vitro and in vivo
por: Xu, Li-Juan, et al.
Publicado: (2017)

WHO grade has no prognostic value in the pediatric high-grade glioma included in the HERBY trial
por: Varlet, Pascale, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_snkuv7kvg7e93h6e2f0m311lhm